Inhibition of CDK2, CDK4 and cyclin E and increased expression of p27Kip1 during treatment with interferon-alpha in carcinoid tumor cells

J Biol Regul Homeost Agents. 1999 Oct-Dec;13(4):207-15.

Abstract

IFN-alpha has presented antitumor effect in about 50% of carcinoid tumor patients, though the antitumor mechanism of IFN-alpha is still to be elucidated. In this study we demonstrated that IFN-alpha could result in accumulation of S-phase population and upregulation of cyclin-dependent kinase inhibitor (CKI), p27. Moreover, IFN-alpha inhibits DNA synthesis assessed by [3H] thymidine incorporation and colony formation on soft agar. Immunodepletion of p27 increased CDK2- and cyclin E-associated kinase activities. These data suggest that IFN-alpha exerts its antiproliferative effects in the neuroendocrine differentiated cell lines by: 1) inhibition of DNA synthesis and colony formation, 2) upregulation on the mRNA and protein expressions of the CKI, p27.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2',5'-Oligoadenylate Synthetase / genetics
  • 2',5'-Oligoadenylate Synthetase / metabolism
  • CDC2-CDC28 Kinases*
  • Carcinoid Tumor / drug therapy*
  • Carcinoid Tumor / enzymology*
  • Carcinoid Tumor / pathology
  • Carcinoid Tumor / secondary
  • Cell Cycle / drug effects
  • Cell Cycle Proteins*
  • Cell Division / drug effects
  • Colonic Neoplasms / pathology
  • Cyclin E / antagonists & inhibitors*
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • DNA / biosynthesis
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • GTP-Binding Proteins*
  • Humans
  • Interferon Regulatory Factor-1
  • Interferon Type I / pharmacology*
  • Interferon Type I / therapeutic use
  • Lymphatic Metastasis
  • Microtubule-Associated Proteins / antagonists & inhibitors
  • Microtubule-Associated Proteins / biosynthesis*
  • Myxovirus Resistance Proteins
  • Pancreatic Neoplasms / pathology
  • Phosphoproteins / genetics
  • Phosphoproteins / metabolism
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Proteins / genetics
  • Proteins / metabolism
  • Proto-Oncogene Proteins*
  • RNA, Messenger / biosynthesis
  • Recombinant Proteins
  • Thymidine / metabolism
  • Tumor Cells, Cultured
  • Tumor Stem Cell Assay
  • Tumor Suppressor Proteins*

Substances

  • Cell Cycle Proteins
  • Cyclin E
  • DNA-Binding Proteins
  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • Interferon Type I
  • Microtubule-Associated Proteins
  • Myxovirus Resistance Proteins
  • Phosphoproteins
  • Proteins
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Recombinant Proteins
  • Tumor Suppressor Proteins
  • Cyclin-Dependent Kinase Inhibitor p27
  • DNA
  • Protein Serine-Threonine Kinases
  • CDC2-CDC28 Kinases
  • CDK2 protein, human
  • CDK4 protein, human
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinases
  • 2',5'-Oligoadenylate Synthetase
  • GTP-Binding Proteins
  • Thymidine